inhibition of some pathways related to apoptosis, autophagy, oxidative stress, inflammation, α-synuclein aggregation, and dopamine loss in PD. In addition, melatonin improves some nonmotor symptom in patients with PD. Limited studies, however, have evaluated the role of melatonin on molecular mechanisms and clinical symptoms in PD. This review summarizes what is known regarding the impact of melatonin on PD in preclinical and clinical studies.
Melatonin and Parkinson Disease: Current ... - Cure Parkinson's
Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
New and current hope for Parkinson's Disease
had a DAT scan which confirm a problem in the dopamine production. Have tried various RX, Physical...
Citicoline in Parkinson's Disease
references to many studies regarding Citicoline. I am interested in the section 'Other clinical...
Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson’s Disease 2021
effects. The aim of this study was to evaluate the effect of melatonin on oxidative stress markers,...
The Endotoxin Hypothesis of Parkinson's Disease
gut wall and blood, which promotes both α-synuclein aggregation in the enteric neurons and a...
Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: A critical perspective review
perspective review 2020 https://pubmed.ncbi.nlm.nih.gov/32652199/
This review considers the crucial...
Causes of Parkinson's Disease
Hitler had Parkinson's disease
Covid and Parkinson's Disease
